Kevin Tang, Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 1,300,000 shares at $10.12 ($13.6M) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Open-market purchase of $13.6M AUPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.12 | 1,000,000 | $10.1M | 74.5% |
| 2 | $11.34 | 100,000 | $1.1M | 8.3% |
| 3 | $11.68 | 200,000 | $2.3M | 17.2% |
| Total | $10.45 avg | 1,300,000 | $13.6M | 100% |
| Filing → |
| FULC | BUY | 2026-07-20 | $595K | — | Filing → |
| BOLD | BUY | 2026-07-16 | $156K | — | Filing → |
| FULC | BUY | 2026-07-15 | $891K | — | Filing → |